Sonic Healthcare Limited (ASX:SHL) signed binding agreement to acquire Pathology Watch Inc. for $130 million on November 16, 2023. The purchase price of $130 million (cash and debt free) will be funded from Sonic?s existing cash and debt facilities. Pathology Watch current run rate annual revenues of $15 million. The founders, management team and staff of Pathology Watch will join Sonic?s USA and global team structures. The transaction is subject to customary conditions and is expected to close in December 2023. The Pathology Watch acquisition is attractive to Sonic. Peter Fusco, R. Kirkie Maswoswe, William Wilson, Roger A. Cohen, George Davis, Alexandra S. Denniston, Timothy Holahan, Paul S. Jin, Steven Tjoe, Cecelia Lockner, Amy S. Josselyn and Ce Li of Goodwin Procter LLP acted as legal advisors to Pathology Watch Inc.

Sonic Healthcare Limited (ASX:SHL) completed the acquisition of Pathology Watch Inc. for $150 million in January 2024.